On Thursday, Baxter International Inc. (NYSE:BAX) reported a first-quarter 2025 adjusted EPS of 62 cents, beating the management guidance of 47 to 50 cents and the Wall Street estimate of 48 cents.
Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Baxter International beat Wall Street expectations for fourth-quarter sales and profit on Thursday on strong demand ...
May 1 (Reuters) - Medical products maker Baxter International (BAX.N), opens new tab on Thursday beat Wall Street estimates for first-quarter revenue and profit, helped by the robust demand for its ...
LAS VEGAS—Clinical teams working in hospitals are constantly on the move, keeping up with urgent demands in a fast-paced environment. Baxter International saw an opportunity to offer voice-activated, ...
Baxter International Inc. (BAX), headquartered in Deerfield, Illinois, is a global leader in healthcare solutions, specializing in medical devices, pharmaceuticals, and biotechnology products. With a ...
The pumps streamline the training clinicians need and help reduce the burden of properly operating multiple disparate pump platforms. Baxter's Novum IQ LVP supports high-volume infusions at faster ...
(Reuters) - Baxter International on Tuesday raised its annual profit expectations and beat Wall Street estimates for second-quarter profit on strong sales of its medical devices, driven by robust ...
Baxter International Inc. (NYSE:BAX) announced today it has issued an Urgent Medical Device Recall for Life2000 ventilators with an attached battery charger dongle. The recall is due to reports that ...
Baxter International Inc. will report fourth-quarter results before the market opens Thursday, a pivotal test for the medical-device maker’s turnaround efforts after years of operational struggles ...
Baxter International Inc. (NYSE:BAX) announced today it has issued an Urgent Medical Device Recall for certain lots of the Volara system single-patient use circuit and blue ventilator adapter assembly ...
Feb 8 (Reuters) - Baxter International BAX.N beat Wall Street expectations for fourth-quarter sales and profit on Thursday on strong demand for its medical devices and improvements in the supply chain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results